• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP
  • LOG IN

Pfiz­er and oth­er bio­phar­mas to FDA: Don't in­clude CMOs in new re­port­ing re­quire­ments on drug vol­ume

4 years ago
FDA+
Manufacturing

No­var­tis is 'all in' on siR­NA, ink­ing a new col­lab­o­ra­tion with Al­ny­lam to de­vel­op al­ter­na­tive to liv­er trans­plants

4 years ago
Deals

So­sei and Ver­i­ly part­ner on GPCRs; Ob­sE­va touts PhI­II da­ta in en­dometrio­sis pain

4 years ago
News Briefing

Sang­amo's sick­le cell al­liance with Sanofi grinds to a halt as phar­ma gi­ant switch­es fo­cus to al­lo

4 years ago
R&D

Covid-19 roundup: In­vestors call to link CEO salaries to vac­cine ac­cess; Why there aren't more ini­tial sup­plies of ...

4 years ago
Coronavirus

Fore­site's im­munol­o­gy play gets a $200M megaround for TYK2 pro­gram, re­brand­ing as Alu­mis

4 years ago
Financing

Mer­ck KGaA beefs up its mR­NA work with a $780M buy­out of a boom­ing play­er

4 years ago
Deals
Cell/Gene Tx

Long­time Zymeworks CEO, co-founder Tehrani hits the ex­it in fa­vor of se­r­i­al biotech en­tre­pre­neur

4 years ago
People

MIT spin­out Con­tin­u­us calls up­on Skan­s­ka to build MA site with fed­er­al de­fense mon­ey

4 years ago
Manufacturing

Seat­tle Chil­dren's col­lab­o­ra­tion to dive in­to cell ther­a­py man­u­fac­tur­ing; Af­ter suc­cess in court, Te­va found guilty ...

4 years ago
Manufacturing

Biosim­u­la­tion out­fit nets $15M Se­ries A in push to make pre­clin­i­cal R&D more pre­dictable

4 years ago
Financing
Startups

A year af­ter ex­pan­sion in Penn­syl­va­nia, Al­ta­sciences scoops up CRO to spread to Mid­west

4 years ago
Manufacturing

Am­gen part­ners with Flag­ship's ma­chine learn­ing start­up, promis­ing up to $1.9B as Big Phar­ma ups bet on AI

4 years ago
Deals
AI

John Maraganore want­ed to be­come a biotech grand­dad af­ter leav­ing Al­ny­lam. With his new role at RTW, it looks like he ...

4 years ago
People

In new post-Mer­ck role, Roger Perl­mut­ter rakes in half a bil­lion dol­lars to change the way sci­en­tists look at ...

4 years ago
R&D

Gary Glick puts Odyssey's $218M cash stack to use, ac­quir­ing ma­chine learn­ing out­fit

4 years ago
Deals
AI

You know AAV and LNP. What about PLV? Eli Lil­ly lines up new ve­hi­cle to de­liv­er its ge­net­ic med­i­cines

4 years ago
Deals
Cell/Gene Tx

A new $1B biotech man­u­fac­tur­ing hub is on its way to the red-hot NC life sci­ences clus­ter

4 years ago
Manufacturing

Te­va and No­var­tis’ San­doz launch Nar­can gener­ics on same day, brand mar­keter Emer­gent re­mains in play

4 years ago
Pharma
Marketing

FDA+ roundup: Agency re­struc­tures chief sci­en­tist's of­fice; First vote on Rob Califf as com­mis­sion­er pushed to next ...

4 years ago
FDA+

Spec­trum hits the re­set but­ton, slic­ing away 30% of its work­force in piv­ot around 2 lead as­sets

4 years ago
People
R&D

An­nex­on shares fall 33% af­ter pa­tients drop out of Hunt­ing­ton's tri­al; Two Chi­nese biotechs net mod­est fi­nanc­ing ...

4 years ago
News Briefing

Clover Bio­phar­ma­ceu­ti­cals sets up a new R&D cen­ter in a buzzy Chi­nese hub near Shang­hai

4 years ago
R&D
China

Blue­print­'s long­time CEO pre­pares to step down as biotech rev­els in new Ay­vak­it launch, pipeline ex­pan­sion

4 years ago
People
First page Previous page 594595596597598599600 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times